Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia

Seminars in Oncology

Volumn 30, Issue 2, 2003, Pages 110-115

  Owen, Roger G ^{a,b,c,d,e,f,g,h}   Treon, Steven P ^{a,b,c,d,e,f,g,h}   Al Katib, Ayad ^{a,b,c,d,e,f,g,h}   Fonseca, Rafael ^{a,b,c,d,e,f,g,h}   Greipp, Philip R ^{a,b,c,d,e,f,g,h}   McMaster, Mary L ^{a,b,c,d,e,f,g,h}   Morra, Enrica ^{a,b,c,d,e,f,g,h}   Pangalis, Gerassimos A ^{a,b,c,d,e,f,g,h}   San Miguel, Jesus F ^{a,b,c,d,e,f,g,h}   Branagan, Andrew R ^{a,b,c,d,e,f,g,h}   Dimopoulos, Meletios A ^{a,b,c,d,e,f,g,h}  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c Van Elslander Cancer Center   (United States)

^d MAYO CLINIC   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f OSPEDALE NIGUARDA CA GRANDA   (Italy)

^g UNIVERSITY OF SALAMANCA   (Spain)

^h UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M; PARAPROTEIN;

BONE MARROW BIOPSY; CLINICAL FEATURE; CONFERENCE PAPER; GREECE; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTIC INFILTRATION; LYMPHOMA; LYMPHOPLASMACYTIC LYMPHOMA; MEDICAL SOCIETY; MONOCLONAL IMMUNOGLOBULINEMIA; PATHOGENESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; WALDENSTROEM MACROGLOBULINEMIA; WORLD HEALTH ORGANIZATION;

EID: 0037396214     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2003.50082     Document Type: Conference Paper

References (41)

1. Waldenström J: Incipient myelomatosis or essential hyperglobulinemia with fibrinogenopenia - A new syndrome? Acta Med Scand 117:216-247, 1944
2. Dimopoulos MA, Panayiotidis P, Moulopoulos LA, et al: Waldenström's macroglobulinemia: Clinical features, complications, and management. J Clin Oncol 18:214-226, 2000
3. Owen RG, Johnson SA, Morgan GJ: Waldenström's macroglobulinaemia: Laboratory diagnosis and treatment. Hematol Oncol 18:41-49, 2000
4. Nakata M, Matsuno Y, Takenaka T, et al: B-cell lymphoma accompanying monoclonal macroglobulinemia with features suggesting marginal zone B-cell lymphoma. Int J Hematol 65:405-411, 1997
5. Allez M, Mariette X, Linares G, et al: Low-grade MALT lymphoma mimicking Waldenström's macroglobulinemia. Leukemia 13:484-485, 1999
6. Valdez R, Finn WG, Ross CW, et al: Waldenström macroglobulinemia caused by extranodal marginal zone B-cell lymphoma. Am J Clin Pathol 116:683-690, 2001
7. Harris NL, Jaffe ES, Stein H, et al: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361-1392, 1994
8. Jaffe ES, Harris NL, Stein H, et al: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France, IARC Press, 2001
9. Owen RG, Parapia LA, Richards SJ, et al: Paraprotein status in lymphoplasmacytoid lymphoma/immunocytoma: Do all cases correspond to Waldenström's macroglobulinaemia? Br J Haematol 105:89, 1999 (suppl 1, abstr)
10. Papamichael D, Norton AJ, Foran JM, et al: Immunocytoma: A retrospective analysis from St Bartholomew's Hospital-1972 to 1996. J Clin Oncol 17:2847-2853, 1999
11. H gene analysis of clonally related IgM and IgG from human lymphoplasmacytoid B-cell tumors with chronic lymphocytic leukemia features and high serum monoclonal IgG. Blood 91:236-243, 1998
12. Moore DF, Migliore PJ, Shullenberger CC, et al: Monoclonal macroglobulinemia in malignant lymphoma. Ann Intern Med 72:43-47, 1970
13. Kyle RA, Garton JP: The spectrum of IgM monoclonal gammopathy in 430 cases. Mayo Clin Proc 62:719-731, 1987
14. Kyle RA, Rajkumar SV: Monoclonal gammopathies of undetermined significance. Hematol Oncol Clin North Am 13:1181-1201, 1999
15. Owen RG, Parapia LA, Higginson J, et al: Clinicopathological correlates of IgM paraproteinemias. Clin Lymph 1:39-43, 2000
16. Facon T, Brouillard M, Duhamel A, et al: Prognostic factors in Waldenström's macroglobulinemia: A report of 167 cases. J Clin Oncol 11:1553-1558, 1993
17. Gobbi PG, Bettini R, Montecucco C, et al: Study of prognosis in Waldenström's macroglobulinemia: A proposal for a simple binary classification with clinical and investigational utility. Blood 83:2939-2945, 1994
18. Morel P, Monconduit M, Jacomy D, et al: Prognostic factors in Waldenström macroglobulinemia: A report on 232 patients with the description of a new scoring system and its validation on 253 other patients. Blood 96:852-858, 2000
19. Owen RG, Barrans SL, Richards SJ, et al: Waldenström macroglobulinemia: Development of diagnostic criteria and identification of prognostic factors. Am J Clin Pathol 116:420-428, 2001
20. Garcia-Sanz R, Montoto S, Torrequebrada A, et al: Waldenström macroglobulinaemia: Presenting features and outcome in a series with 217 cases. Br J Haematol 115:575-582, 2001
21. Kyrtsonis MC, Vassilakopoulos TP, Angelopoulou MK, et al: Waldenström's macroglobulinemia: Clinical course and prognostic features in 60 patients. Ann Hematol 80:722-727, 2001
22. Bartl R, Frisch B, Mahl G, et al: Bone marrow histology in Waldenström's macroglobulinaemia. Scand J Haematol 3:359-375, 1983
23. Andriko JW, Aguilera NS, Chu WS, et al: Waldenström's macroglobulinemia. A clinicopathologic study of 22 cases. Cancer 80:1926-1935, 1997
24. Feiner HD, Rizk CC, Finfer MD, et al: IgM monoclonal gammopathy/Waldenstr6m's macroglobulinemia: A morphological and immunophenotypic study of the bone marrow. Mod Pathol 3:348-356, 1990
25. Matutes E, Owusu-Ankomah K, Morilla R, et al: The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 8:1640-1645, 1994
26. Kelliher A, Preffer F, Frankel SR, et al: Expression of serotherapy target antigens in lymphoplasmacytic lymphoma (Waldenstrom's macroglobulinemia). Proc Am Soc Clin Oncol 21:279a, 2002 (abstr)
27. San Miguel JF, Vidriales MB, Mateo G, et al; Immunophenotypic analysis of Waldenström's macroglobulinemia. Semin Oncol 30:187-195, 2003
28. Leitch D, O'Connor SJM, Barrans SL, et al: Waldenstrom's macroglobulinemia is characterised by a memory B-cell immunophenotype and the absence of immunoglobulin translocations. Blood 100:347a, 2002 (suppl 1, abstr)
29. Zarrabi MH, Stark RS, Kane P, et al: IgM myeloma, a distinct entity in the spectrum of B-cell neoplasia. Am J Clin Pathol 75:1-10, 1981
30. Takahashi K, Yamamura F, Motoyama H: IgM myeloma - Its distinction from Waldenström's macroglobulinemia. Acta Pathol Jpn 36:1553-1563, 1986
31. Haghighi B, Yanagihara R, Cornbleet PJ: IgM myeloma: Case report with immunophenotypic profile. Am J Clin Pathol 59:302-308, 1998
32. Konda H, Yokoyama K: IgM myeloma: Different features from multiple myeloma and macroglobulinaemia. Eur J Haematol 63:366-368, 1999
33. Dierlamm T, Laack E, Dierlamm J, et al: IgM myeloma: A report of four cases. Ann Hematol 81:136-139, 2002
34. Avet-Loiseau H, Garand R, Lode L, et al: 14q32 translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemia. Semin Oncol 30:153-155, 2003
35. Palka G, Spadano A, Geraci L, et al: Chromosome changes in 19 patients with Waldenström's macroglobulinemia. Cancer Genet Cytogenet 29:261-269, 1987
36. Louviaux I, Michaux L, Hagemeijer A, et al: Cytogenetic abnormalities in Waldenstöm's disease (WD): A single center study on 45 cases. Blood 92:3776, 1998 (suppl 1, abstr)
37. Carbone P, Caradonna F, Granata G, et al: Chromosomal abnormalities in Waldenström's macroglobulinemia. Cancer Genet Cytogenet 61:147-151, 1992
38. Mansoor A, Medeiros J, Weber DM, et al: Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course. Am J Clin Pathol 116:543-549, 2001
39. Schop RFJ, Kuehl WM, Van Wier SA, et al: Waldenström's macroglobulinemia neoplastic cells lack IgH translocations but have frequent 6q deletions. Blood 100:2996-3001, 2002
40. Offit K, Parsa NZ, Filippa D, et al: t(9;14)(p13;q32) denotes a subset of low-grade non-Hodgkin's lymphoma with plasmacytoid differentiation. Blood 80:2594-2599, 1992
41. Iida S, Rao PH, Nallasivam P, et al: The t(9;14)(p13; q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. Blood 88:4110-4117, 1996